Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
clinical trials
3
×
fda
life sciences
national blog main
san diego blog main
3
×
san diego top stories
antibiotics
boston
boston blog main
boston top stories
drugs
new york blog main
san diego
achaogen
adams street partners
arvinas
astrazeneca
beta lactamase inhibitor
biomedical advanced research and development authority (barda)
biotech ipos
boulder/denver
boulder/denver blog main
boulder/denver top stories
carbapenem-resistant enterobacteriaceae
celgene
deals
detroit
detroit blog main
detroit top stories
drug resistance
dyne therapeutics
entasis therapeutics
gritstone oncology
guardant health
hatteras venture partners
indiana
indiana blog main
indiana top stories
investing
What
company
3
×
drug
ipo
medicines
therapeutics
bacteria
biopharma
biotechs
brings
business
chose
close
developing
device
disease
disorders
dyne
dyne’s
exited
fighting
firms
genetic
infections
infectious
ipos
launches
life
make
medical
melinta
million
muscle
muscular
open
preclinical
products
q
qpex
quarter
raised
Language
unset
Current search:
biotech
×
" san diego blog main "
×
" clinical trials "
×
company
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way